Related Experiment Video
Updated: Jun 8, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Imaging blood-brain barrier dysfunction in drug-resistant epilepsy: A multi-center feasibility study
Nir Cafri1,2,3, Sheida Mirloo4, Daniel Zarhin3
1Department of Physiology, Professor Vladimir Zelman Inter-Disciplinary Center of Brain Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Patients with epilepsy show significantly more blood-brain barrier dysfunction (BBBD) in greater brain volumes compared to healthy individuals. This dysfunction may be a key factor in epilepsy development, suggesting microvascular stabilization as a therapeutic target.
Area of Science:
- Neurology
- Neuroimaging
- Vascular Biology
Background:
- Blood-brain barrier dysfunction (BBBD) is implicated in neurological disorders.
- Epilepsy is a neurological disorder where BBBD may play a role.
Purpose of the Study:
- To identify and compare brain regions with BBBD in patients with epilepsy (PWE) and healthy individuals using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI).
Main Methods:
- DCE-MRI scans were performed on 50 drug-resistant epilepsy (DRE) patients and 58 healthy controls across four international epilepsy centers.
- Analysis focused on the presence and extent of BBBD, comparing PWE with controls.
Main Results:
- PWE exhibited significantly greater brain volume and a higher number of brain regions with BBBD compared to controls (p < 10⁻⁷).
- No significant differences in total brain volume with BBBD were found between focal and generalized epilepsy types, or between PWE with and without MRI-visible lesions.
- BBBD was detected in seizure onset zones in 82% of PWE, often near or within the suspected epileptogenic lesion.
Conclusions:
- Findings support the role of BBBD in the development of DRE.
- Microvascular stabilization emerges as a potential therapeutic strategy for epilepsy.
More Related Videos
08:23A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
Published on: November 13, 2016
07:22Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease
Published on: November 8, 2017
Related Concept Videos
The Blood-brain Barrier
Arteries of the Lower Limbs
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...